and an ophthalmoscope before surgery. A lens examination was performed according to the Lens Opacities Classification System III (LOCSIII), including grading of nuclear opalescence and color (N; 0.1-6.9), cortical opacity (C; 0.1-5.9), and subcapsular opacity (P; 0.1-5.9) [15] . Only patients with pure cortical opacity with grades of more than LOCS 2 and patients without nuclear or posterior capsule opacity were included in this study [16] . For the control subjects, all parameters of the LOCSIII grading system were lower than LOCS 2. All subjects gave their informed consent to be included in the study, which was approved by the ethics committees of the participating institutions.
Genotyping: The genomic DNA was extracted from 5 to 10 ml of peripheral whole blood from all participants, as well as purified from lymphocyte pellets according to standard procedures using a Puregene DNA isolation kit (Gentra Systems, Minneapolis, MN). The primer sequences used in the PCR analysis are shown in Table 1 . PCR was performed in a 25-μl reaction volume containing 2.5 μl 10 × GC buffer (Tiangen, Beijing, and China), 200 μmol/l of dNTP, 0.2 μmol/l of each primer, 1.0 unit of Tag DNA polymerase (Tiangen), and 60 ng of genomic DNA. The conditions, after initial denaturation at 95 °C for 15 min, were 35 cycles of 30 s at 94 °C, 1 min at 50-62 °C, and 1 min at 72 °C, followed by a final extension at 72 °C for 7 min. The products of PCR remained at 4 °C and they were purified using a MultiScreen-PCR plate (Millipore). The purified PCR products were bi-directionally sequenced using the ABI 3730 DNA sequencer (Applied Biosystems, Foster City, CA).
Statistics:
Allele frequencies of all single nucleotide polymorphisms (SNPs) detected were assessed for Hardy-Weinberg equilibrium (HWE) using a chi-square (χ2) test with a one degree of freedom. The distributions of allele and genotype frequencies in patients were compared with those of the control subjects using the χ2 test or Fisher's exact test. As well, a p value of <0.05 was considered statistically significant based on previous reports. The strength of the association of the genotypes with cataracts (expressed as the odds ratio [OR] and 95% confidence interval [CI]) was obtained from the 2 × 2 contingency tables. Bonferroni's correction was applied to adjust the significance level in multiple comparisons, and a p value of less than 0.017 (equal to 0.05/3) was considered statistically significant [17] . All calculations were performed with the SPSS software, version 15.0 (SPSS Science, Chicago, IL).
RESULTS
We included 227 unrelated Chinese patients with cataracts (mean age, 65.6±6.0 years; 55% females) and 263 unrelated control subjects (mean age, 64.5±5.6 years; 50% females). There was no significant difference in age and gender between the two groups.
Allele frequencies and genotypes in patients and control subjects were listed in Table 2 . The genotype distribution was in agreement with the HWE both in the control subjects and the patients (p>0.05, data shown in Table 2 ). Based on the corrected p value at p=0.017, there is no statistically significant difference among allele frequencies and genotypes for PSEN1 rs7523 (allele P Stratification by APOE showed a possible association between the KLC1 (rs8702) polymorphism and cataracts, depending on the APOE genotype (Table 3) . Thus, among individuals devoid of the APOE4 allele, the rs8072 C allele was less common in cases (48% C allele carriers) than in controls (62%), and the association was significant after Bonferroni's correction (genotype P[χ2]=0.003; OR=0.55). Among APOE4 carriers, although the rs8702 C allele was less common in the cataract cases (70%) compared to the controls (80%), the association was not significant (genotype P[χ2]=0.36; OR=0.57). These results indicate that the KLC1 (rs8702) C allele reduces cortical cataract risk among individuals devoid of the APOE4 allele, whereas it has no significant effect on APOE4 carriers.
DISCUSSION
Cataracts and AD were supposed to be associated [18] . This study analyzed the relationship between cataracts and the PSEN1, KLC1, and APOE genes in the Han Chinese population in Northeastern China. Our statistical analyses showed that these three genes were not associated with cataracts in that population.
Multiple studies suggest that genetic variations in the coding and promoter regions of PSEN may affect AD susceptibility [19] or the rate of cognitive impairment progression [20] . Presenilins are key components of the secretase multiprotein complexes that are responsible for Alzheimer precursor protein (AβPP) processing, as well as the generation of the cytotoxic β-amyloid polypeptide (Aβ). Both PSEN1 and PSEN2 are known to be expressed in the lens, where the Aβ-polypeptide has been shown to accumulate in the lens *OR with 95% CI, for the individuals carrying one or two copies of the rs8702 C allele (any C) compared with GG genotype.
epithelia of both AD and non-AD patients [8, 21] . However, to our knowledge, an association between PSEN1 and cataracts has not been previously reported. The present study, focusing on the two PSEN1 polymorphisms (rs165932 and rs7523), showed that no differences in the distribution of the T (rs165932) and A (rs7523) alleles and genotypes could be seen between the controls and cataract patients.
Kinesin molecular motor proteins generate the movement of vesicles containing a wide variety of materials in neuronal and other cells, and they are [22] also expressed in the lens [23] . Further, although much more speculative, some biochemical and epidemiological data support an association between cataracts and AD [18] . It is reported that the GG genotype of rs8702 in KLC1 represents a high risk for cataracts in the Estonian population [13] . The KLC1 rs8702 allele and genotype frequencies found in this study are different from those reported in other European populations [13, 14] . Moreover, our results point to a possible relation to cataracts in an APOE-dependent manner, with evidence suggesting that the rs8702 polymorphism influences the risk of developing cataracts without APOE4 carriers. Thus, more studies are necessary to validate this result, as well as to determine the mechanisms responsible for the association in the future.
Zetterberg et al. performed genotyping of APOE on 502 patients with senile cataracts, as well as on 187 individuals in a control group, without finding any significant difference for any APOE alleles [7] . This indicates that if there is a common pathogenic mechanism between cataracts and AD, it does not involve the APOE polymorphism. However, Utheim et al. tested their results further by examining 88 healthy individuals for cataracts, half of whom were APOE4 carriers, and a weak negative association between APOE4 and cataracts was disclosed [24] . In the present study, the APOE4 allele was more frequent in cases than in controls (p=0.03), but the difference was not significant after Bonferroni's correction.
Altogether, these results do not support PSEN1 as a major susceptibility gene for cataracts. A small influence of APOE or KLC1 (rs8702) on the risk of cataracts cannot be excluded, but it must be confirmed by additional replication studies as well as experimental studies showing a functional effect of these SNPs.
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